MedPath

Skeletal Muscle and Adipose Tissue Study

Phase 4
Completed
Conditions
Idiopathic Scoliosis
Interventions
Drug: Continuous Cefazolin drip
Drug: Bolus dose of Cefazolin
Device: Paraspinal muscle microdialysis catheters
Device: Subcutaneous microdialysis catheters
Registration Number
NCT03190668
Lead Sponsor
University of Florida
Brief Summary

The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.

Detailed Description

Determine the skeletal muscle and adipose tissue disposition of prophylactic Cefazolin using microdialysis sampling in a cohort of patients diagnosed with idiopathic scoliosis undergoing posterior spinal fusion (PSF) for administration of Cefazolin by either continuous infusion or intermittent bolus.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Diagnosis of idiopathic scoliosis
  • Planned posterior spinal fusion surgery (PSFS)
  • Age: 12-20 years old
  • American Society of Anesthesiology status I or II undergoing posterior spinal fusion for at least 6 levels
  • No known allergy to cefazolin
Read More
Exclusion Criteria
  • Known allergy to cefazolin
  • Anatomical or other abnormalities that precluded insertion of a microdialysis catheter into the selected paraspinal muscle
  • Known renal or hepatic insufficiency or failure
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
First Regimen GroupSubcutaneous microdialysis cathetersThe first regimen will consist of a bolus dose of Cefazolin 30mg/kg up to a maximum of 2000mg IV administered prior to surgical incision. The same pre-operative dose of Cefazolin will be repeated every 3 hours until the completion of surgery. Two will paraspinal muscle microdialysis catheters and two subcutaneous microdialysis catheters will be inserted.
Second Regimen GroupContinuous Cefazolin dripThe second regimen will consist of an initial bolus dose of 30 mg/kg up to maximum of 2000 mg. Following the initial bolus dose a continuous Cefazolin drip will start until the end of surgery. Cefazolin drip dose will be 10 mg/(kg\*h) up to maximum of 667 mg/h.Two microdialysis catheters will be inserted into a paraspinal muscle and two microdialysis catheters will be inserted subcutaneously.
Second Regimen GroupParaspinal muscle microdialysis cathetersThe second regimen will consist of an initial bolus dose of 30 mg/kg up to maximum of 2000 mg. Following the initial bolus dose a continuous Cefazolin drip will start until the end of surgery. Cefazolin drip dose will be 10 mg/(kg\*h) up to maximum of 667 mg/h.Two microdialysis catheters will be inserted into a paraspinal muscle and two microdialysis catheters will be inserted subcutaneously.
First Regimen GroupBolus dose of CefazolinThe first regimen will consist of a bolus dose of Cefazolin 30mg/kg up to a maximum of 2000mg IV administered prior to surgical incision. The same pre-operative dose of Cefazolin will be repeated every 3 hours until the completion of surgery. Two will paraspinal muscle microdialysis catheters and two subcutaneous microdialysis catheters will be inserted.
Second Regimen GroupSubcutaneous microdialysis cathetersThe second regimen will consist of an initial bolus dose of 30 mg/kg up to maximum of 2000 mg. Following the initial bolus dose a continuous Cefazolin drip will start until the end of surgery. Cefazolin drip dose will be 10 mg/(kg\*h) up to maximum of 667 mg/h.Two microdialysis catheters will be inserted into a paraspinal muscle and two microdialysis catheters will be inserted subcutaneously.
First Regimen GroupParaspinal muscle microdialysis cathetersThe first regimen will consist of a bolus dose of Cefazolin 30mg/kg up to a maximum of 2000mg IV administered prior to surgical incision. The same pre-operative dose of Cefazolin will be repeated every 3 hours until the completion of surgery. Two will paraspinal muscle microdialysis catheters and two subcutaneous microdialysis catheters will be inserted.
Primary Outcome Measures
NameTimeMethod
Unbound Cefazolin Concentration in Skeletal MuscleChanges from baseline (pre-op) up to end of surgical procedure

First regimen and second regimen difference between unbound Cefazolin concentrations in the interstitial fluid of skeletal muscle

Unbound Cefazolin in Adipose TissueChanges from baseline (pre-op) up to end of surgical procedure

First regimen and second regimen difference between unbound Cefazolin concentrations in the interstitial fluid of adipose tissue

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath